Publications

EUNCL Presentation at NanoMed Workshop Paris
(PDF, 5.6 MB)

European Infrastructure to improve translation in nanomedicine
(PDF, 12.9 MB)

EUNCL Call Campaign
(PDF, 0.3 MB)

The European Nanomedicine Characterisation Laboratory
(PDF, 2.2 MB)

EUNCL Overview
(PDF, 3.9 MB)

Perspectives on the Start-Up of EUNCL
(PDF, 2.5 MB)

Are existing standard methods suitable for the evaluation of nanomedicines: some case studies
(PDF, 2.7 MB)

Nanomedicine Translation Hub and EU-NCL: Custom mentoring, product characterization and GMP manufacturing of Med-NPs
(PDF, 5.8 MB)

Lessons learned
(PDF, 9.6 MB)

The use of nanotechnology in medical products has been demonstrated at laboratory scale, and many resulting nanomedicines are in the translational phase toward clinical applications, with global market trends indicating strong growth of the sector in the coming years. The translation of nanomedicines toward the clinic and subsequent commercialization may require the development of new or adaptation of existing standards to ensure the quality, safety and efficacy of such products. This work addresses some identified needs, and illustrates the shortcomings of currently used standardized methods when applied to medical-nanoparticles to assess particle size, drug loading, drug release and in vitro safety. Alternative physicochemical, and in vitro toxicology methods, with the potential to qualify as future standards supporting the evaluation of nanomedicine are provided.

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!

News

  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.
  • CLINAM 2018 with EUNCL Participation
    It was the 11th Summit of its kind. CLINAM again welcomed the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine.
  • Trainee position at JRC (5 months)
    The Consumer Products Safety Unit (F.2), part of Health, Consumers and Reference Materials Directorate-F at the JRC in Ispra (Italy), is looking for a trainee for the Nanobiotechnology laboratory.

More News ...